Track Intuitive Surgical, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Intuitive Surgical, Inc. ISRG · Stock Open Intuitive Surgical, Inc. in new tab

443.59 USD
P/E
54.36
EPS
8.27
P/B
9.75
ROE
17.93
Beta
1.44
Target Price
486.57 USD
Intuitive Surgical, Inc. logo

Intuitive Surgical, Inc.

🧾 Earnings Recap – Q3 2026

Intuitive’s shares fell 2.3% after earnings, a roughly flat reaction that suggests a measured response to the quarter rather than a clear market verdict. Procedure growth and system placements were solid, while the company’s new pricing actions for some high-volume benign procedures are expected to affect financial results.

  • Total procedures grew 15% year over year: da Vinci procedures increased 14% and Ion procedures 31%. Da Vinci growth was 10% in the U.S. and 20% outside the U.S.
  • Da Vinci system placements rose 28% worldwide; da Vinci 5 and SP accounted for 65% of placements. The installed base of da Vinci and Ion systems exceeded 13,200.
  • More than 2,000 da Vinci 5 systems were installed worldwide, and over 18,000 surgeons have used the platform since launch.
  • International da Vinci placements increased 29%. India’s procedures grew 42%, while the company said China’s operating environment remains challenging.
  • Intuitive finalized pricing actions for a subset of high-volume benign procedures, aiming to broaden access. Management said the anticipated financial impact would be discussed later on the call.
📅
Loading chart...
Key Metrics
Earnings dateJan. 28, 2027
P/E54.36
EPS8.27
Book Value46.12
Price to Book9.75
Debt/Equity0.95
% Insiders0.528%
Growth
Revenue Growth0.22%
Earnings Growth-0.24%
Estimates
Forward P/E36.05
Forward EPS12.47
Target Mean Price486.57

DCF valuation

Model fair value for Intuitive Surgical, Inc. (ISRG)
Result
Sign in to run the valuation for ISRG.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
30 analysts · consensus Buy · mean target 486.57 USD (low 324.00, high 685.00) · as of 12 Nov 2026
Low 324.00
Mean 486.57
High 685.00
Price 443.59
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Intuitive Surgical, Inc. Logo Intuitive Surgical, Inc. Analysis (ISRG)

United States Health Care Official Website Stock

Is Intuitive Surgical, Inc. a good investment? Intuitive Surgical, Inc. (ISRG) is currently trading at 443.59 USD. Market analysts have a consensus price target of 486.57 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 54.36. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Intuitive Surgical, Inc. is expected to release its next earnings report on Jan. 28, 2027. The market consensus estimate for Forward EPS is 12.47.

Investor FAQ

Does Intuitive Surgical, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Intuitive Surgical, Inc.?

Intuitive Surgical, Inc. is classified as a Stock. You can compare it against 8 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Jan. 28, 2027. The company currently has a trailing EPS of 8.27.

Company Profile

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.

Exchange Ticker
LSE (United Kingdom) 0R29.L
VIE (Austria) ISRG.VI
IUI1.HM
NMS (United States) ISRG
GER (Germany) IUI1.DE
FRA (Germany) IUI1.F
MEX (Mexico) ISRG.MX
SAO (Brazil) I1SR34.SA
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
July 1, 2003 1:2
Oct. 6, 2017 3:1
Oct. 5, 2021 3:1
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion